Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-AFP in pediatric fistulizing Crohn's disease
NCT03449069Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2018
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Autologous mesenchymal stromal cell coated fistula plug in Crohn's disease and perianal fistula, sponsored by Mayo Clinic. Primary endpoint: Number of participants with treatment-related adverse events at 24 months. Started Jul 2018; status: completed.
02
Drugs
Autologous mesenchymal stromal cell coated fistula plug
03
Conditions
Crohn's diseaseperianal fistula
Beyond the preview
Go deeper on NCT03449069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03449069.